Global Prenatal and Newborn Genetic Testing Market USD 8.7 Billion by 2020

Global Prenatal and Newborn Genetic Testing Market USD 8.7 Billion by 2020

The global prenatal and newborn genetic testing market segmentation is based on technologies (prenatal and newborn genetic diagnostic techniques, array-comparative genomic hybridization, fluorescence in-situ hybridization, polymerase chain reaction, prenatal and newborn genetic screening methods, maternal serum screening, non-invasive prenatal tests such as MaterniT21 PLUS, Verifi, Harmony, Panorama, NIFTY, PrenaTest and Bambni Test).

According to a market research report Prenatal and Newborn Genetic Testing Market 2016-2020, published by iHealthcareAnalyst, Inc., the global prenatal and newborn genetic testing market is estimated to reach USD 8.5 Billion in 2020, expanding at a CAGR of 18.0% from 2016 to 2020.

Visit the Prenatal and Newborn Genetic Testing Market 2016-2020 report at https://www.ihealthcareanalyst.com/report/prenatal-newborn-genetic-testing-market/

The global prenatal and newborn genetic testing market report provides market size (Revenue USD Million 2013 to 2020), market share and forecasts growth trends (CAGR%, 2016 to 2020).

The global prenatal and newborn genetic testing market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and also tracks the major competitors operating in the market and provides analysis of the company overview, financial snapshot, key products, technologies and services offered, market share analysis and recent trends in the global market. The global prenatal and newborn genetic testing market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

  1. Technology
    • Prenatal and Newborn Genetic Diagnostic Techniques
      • Array-Comparative Genomic Hybridization (aCGH)
      • Fluorescence In-Situ Hybridization (FISH)
      • Polymerase Chain Reaction (PCR)
    • Prenatal and Newborn Genetic Screening Methods
      • Maternal Serum Screening (MSS)
      • Non-invasive Prenatal Tests (MaterniT21 PLUS, Verifi, Harmony, Panorama, NIFTY, PrenaTest and Bambni Test, etc.)
  1. Geography (Region, Country)
    • North America (U.S., Canada)
    • Latin America (Brazil, Mexico, Rest of LA)
    • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    • Asia Pacific (Japan, China, India, Rest of APAC)
    • Rest of the World
  1. Company Profiles
    • Agilent Technologies, Inc.
    • Ariosa Diagnostics, Inc.
    • Bio-Rad Laboratories, Inc.
    • Illumina, Inc.
    • Laboratory Corporation of America Holdings (LabCorp)
    • Natera, Inc.
    • PerkinElmer, Inc.
    • Sequenom, Inc.

About Us

iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.

iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.

Contact Us

iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: [email protected]
Website: https://www.ihealthcareanalyst.com


 

2016-10-19T11:32:31+00:00 Categories: Press Releases|